Loading…
Carboranyl-1,8-naphthalimide intercalators induce lysosomal membrane permeabilization and ferroptosis in cancer cell lines
The synthesis of carborane-1,8-naphthalimide conjugates and evaluation of their DNA-binding ability and anticancer activity were performed. A series of 4-carboranyl-3-nitro-1,8-naphthalimide derivatives, mitonafide and pinafide analogs, were synthesised via amidation and reductive amination reaction...
Saved in:
Published in: | Journal of enzyme inhibition and medicinal chemistry 2023-12, Vol.38 (1), p.2171028 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c562t-7d126b089df6b52b5de02133740fa3f457c288488573ab2e570891c6a6d9d9983 |
---|---|
cites | cdi_FETCH-LOGICAL-c562t-7d126b089df6b52b5de02133740fa3f457c288488573ab2e570891c6a6d9d9983 |
container_end_page | |
container_issue | 1 |
container_start_page | 2171028 |
container_title | Journal of enzyme inhibition and medicinal chemistry |
container_volume | 38 |
creator | Rykowski, Sebastian Gurda-Woźna, Dorota Fedoruk-Wyszomirska, Agnieszka Orlicka-Płocka, Marta Kowalczyk, Aleksandra Stączek, Paweł Denel-Bobrowska, Marta Biniek-Antosiak, Katarzyna Rypniewski, Wojciech Wyszko, Eliza Olejniczak, Agnieszka B. |
description | The synthesis of carborane-1,8-naphthalimide conjugates and evaluation of their DNA-binding ability and anticancer activity were performed. A series of 4-carboranyl-3-nitro-1,8-naphthalimide derivatives, mitonafide and pinafide analogs, were synthesised via amidation and reductive amination reactions, and their calf thymus DNA (ct-DNA)-binding properties were investigated using circular dichroism, UV-vis spectroscopy, and thermal denaturation. Results showed that conjugates 34-37 interacted very strongly with ct-DNA (ΔT
m
= 10.00-13.00 °C), indicating their ability to intercalate with DNA, but did not inhibit the activity of topoisomerase II. The conjugates inhibited the cell growth of the HepG2 cancer cell line in vitro. The same compounds caused the G2M phase arrest. Cell lines treated with these conjugates showed an increase in reactive oxygen species, glutathione, and Fe
2+
levels, lipid peroxidation, and mitochondrial membrane potential relative to controls, indicating the involvement of ferroptosis. Furthermore, these conjugates caused lysosomal membrane permeabilization in HepG2 cells but not in MRC-5 cells. |
doi_str_mv | 10.1080/14756366.2023.2171028 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_36715272</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_da14e44f868943c69fa7db724c26232b</doaj_id><sourcerecordid>2917546864</sourcerecordid><originalsourceid>FETCH-LOGICAL-c562t-7d126b089df6b52b5de02133740fa3f457c288488573ab2e570891c6a6d9d9983</originalsourceid><addsrcrecordid>eNp9UstuEzEUHSEQLYVPAI3EhgUT_LZng0ARj0qV2MDaumN7GlceO9iTovTr8ZA0oixY2b4-59zXaZqXGK0wUugdZpILKsSKIEJXBEuMiHrUnC_xTlDJHp_uQpw1z0q5QYhggtnT5owKiTmR5Ly5W0MeUoa4Dx1-q7oI2828geAnb13r4-yygQBzyqW-7M64NuxLKmmC0E5uGirVtVuXJweDD_4OZp9iC9G2o8s5bedU_EJtDUTjcmtcCG3w0ZXnzZMRQnEvjudF8-Pzp-_rr93Vty-X649XneGCzJ20mIgBqd6OYuBk4NbVPmjtEI1AR8alIUoxpbikMBDHZcViI0DY3va9ohfN5UHXJrjR2-wnyHudwOs_gZSvNeTZm-C0BcwcY6MSqmfUiH4EaQdJmCGCUDJUrfcHre1umJw1Ls4ZwgPRhz_Rb_R1utW9WmpEVeDNUSCnnztXZj35ssykjjHtiiayLrJHmC_Q1_9Ab9IuxzoqTXosORNKsIriB5TJqZTsxlMxGOnFKfreKXpxij46pfJe_d3JiXVvjQr4cAD4OKY8wa-Ug9Uz7EPKY9268UXT_-f4DYF7zr4</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2917546864</pqid></control><display><type>article</type><title>Carboranyl-1,8-naphthalimide intercalators induce lysosomal membrane permeabilization and ferroptosis in cancer cell lines</title><source>Open Access: PubMed Central</source><source>Taylor & Francis Open Access</source><source>Publicly Available Content Database</source><creator>Rykowski, Sebastian ; Gurda-Woźna, Dorota ; Fedoruk-Wyszomirska, Agnieszka ; Orlicka-Płocka, Marta ; Kowalczyk, Aleksandra ; Stączek, Paweł ; Denel-Bobrowska, Marta ; Biniek-Antosiak, Katarzyna ; Rypniewski, Wojciech ; Wyszko, Eliza ; Olejniczak, Agnieszka B.</creator><creatorcontrib>Rykowski, Sebastian ; Gurda-Woźna, Dorota ; Fedoruk-Wyszomirska, Agnieszka ; Orlicka-Płocka, Marta ; Kowalczyk, Aleksandra ; Stączek, Paweł ; Denel-Bobrowska, Marta ; Biniek-Antosiak, Katarzyna ; Rypniewski, Wojciech ; Wyszko, Eliza ; Olejniczak, Agnieszka B.</creatorcontrib><description>The synthesis of carborane-1,8-naphthalimide conjugates and evaluation of their DNA-binding ability and anticancer activity were performed. A series of 4-carboranyl-3-nitro-1,8-naphthalimide derivatives, mitonafide and pinafide analogs, were synthesised via amidation and reductive amination reactions, and their calf thymus DNA (ct-DNA)-binding properties were investigated using circular dichroism, UV-vis spectroscopy, and thermal denaturation. Results showed that conjugates 34-37 interacted very strongly with ct-DNA (ΔT
m
= 10.00-13.00 °C), indicating their ability to intercalate with DNA, but did not inhibit the activity of topoisomerase II. The conjugates inhibited the cell growth of the HepG2 cancer cell line in vitro. The same compounds caused the G2M phase arrest. Cell lines treated with these conjugates showed an increase in reactive oxygen species, glutathione, and Fe
2+
levels, lipid peroxidation, and mitochondrial membrane potential relative to controls, indicating the involvement of ferroptosis. Furthermore, these conjugates caused lysosomal membrane permeabilization in HepG2 cells but not in MRC-5 cells.</description><identifier>ISSN: 1475-6366</identifier><identifier>ISSN: 1475-6374</identifier><identifier>EISSN: 1475-6374</identifier><identifier>DOI: 10.1080/14756366.2023.2171028</identifier><identifier>PMID: 36715272</identifier><language>eng</language><publisher>England: Taylor & Francis</publisher><subject>1,8-naphthalimides ; anticancer activity ; Antineoplastic Agents - chemistry ; Antitumor activity ; Biology ; Calf thymus ; Cancer ; Carborane ; Cell cycle ; Cell Line ; Cell Line, Tumor ; Chemistry ; Circular dichroism ; Cytotoxicity ; Deoxyribonucleic acid ; DNA ; DNA - chemistry ; DNA topoisomerase (ATP-hydrolysing) ; Ferroptosis ; Glutathione ; Intercalating Agents ; intercalation ; Lipid peroxidation ; Lysosomes - metabolism ; Membrane potential ; Naphthalimides ; Neoplasms ; Pharmaceutical sciences ; Reactive oxygen species ; Research Paper ; Spectroscopy ; Thermal denaturation ; Thymus gland ; Tumor cell lines</subject><ispartof>Journal of enzyme inhibition and medicinal chemistry, 2023-12, Vol.38 (1), p.2171028</ispartof><rights>2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023</rights><rights>2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c562t-7d126b089df6b52b5de02133740fa3f457c288488573ab2e570891c6a6d9d9983</citedby><cites>FETCH-LOGICAL-c562t-7d126b089df6b52b5de02133740fa3f457c288488573ab2e570891c6a6d9d9983</cites><orcidid>0000-0003-4416-8289</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888480/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2917546864?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27502,27924,27925,37012,37013,44590,53791,53793,59143,59144</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36715272$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rykowski, Sebastian</creatorcontrib><creatorcontrib>Gurda-Woźna, Dorota</creatorcontrib><creatorcontrib>Fedoruk-Wyszomirska, Agnieszka</creatorcontrib><creatorcontrib>Orlicka-Płocka, Marta</creatorcontrib><creatorcontrib>Kowalczyk, Aleksandra</creatorcontrib><creatorcontrib>Stączek, Paweł</creatorcontrib><creatorcontrib>Denel-Bobrowska, Marta</creatorcontrib><creatorcontrib>Biniek-Antosiak, Katarzyna</creatorcontrib><creatorcontrib>Rypniewski, Wojciech</creatorcontrib><creatorcontrib>Wyszko, Eliza</creatorcontrib><creatorcontrib>Olejniczak, Agnieszka B.</creatorcontrib><title>Carboranyl-1,8-naphthalimide intercalators induce lysosomal membrane permeabilization and ferroptosis in cancer cell lines</title><title>Journal of enzyme inhibition and medicinal chemistry</title><addtitle>J Enzyme Inhib Med Chem</addtitle><description>The synthesis of carborane-1,8-naphthalimide conjugates and evaluation of their DNA-binding ability and anticancer activity were performed. A series of 4-carboranyl-3-nitro-1,8-naphthalimide derivatives, mitonafide and pinafide analogs, were synthesised via amidation and reductive amination reactions, and their calf thymus DNA (ct-DNA)-binding properties were investigated using circular dichroism, UV-vis spectroscopy, and thermal denaturation. Results showed that conjugates 34-37 interacted very strongly with ct-DNA (ΔT
m
= 10.00-13.00 °C), indicating their ability to intercalate with DNA, but did not inhibit the activity of topoisomerase II. The conjugates inhibited the cell growth of the HepG2 cancer cell line in vitro. The same compounds caused the G2M phase arrest. Cell lines treated with these conjugates showed an increase in reactive oxygen species, glutathione, and Fe
2+
levels, lipid peroxidation, and mitochondrial membrane potential relative to controls, indicating the involvement of ferroptosis. Furthermore, these conjugates caused lysosomal membrane permeabilization in HepG2 cells but not in MRC-5 cells.</description><subject>1,8-naphthalimides</subject><subject>anticancer activity</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antitumor activity</subject><subject>Biology</subject><subject>Calf thymus</subject><subject>Cancer</subject><subject>Carborane</subject><subject>Cell cycle</subject><subject>Cell Line</subject><subject>Cell Line, Tumor</subject><subject>Chemistry</subject><subject>Circular dichroism</subject><subject>Cytotoxicity</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA - chemistry</subject><subject>DNA topoisomerase (ATP-hydrolysing)</subject><subject>Ferroptosis</subject><subject>Glutathione</subject><subject>Intercalating Agents</subject><subject>intercalation</subject><subject>Lipid peroxidation</subject><subject>Lysosomes - metabolism</subject><subject>Membrane potential</subject><subject>Naphthalimides</subject><subject>Neoplasms</subject><subject>Pharmaceutical sciences</subject><subject>Reactive oxygen species</subject><subject>Research Paper</subject><subject>Spectroscopy</subject><subject>Thermal denaturation</subject><subject>Thymus gland</subject><subject>Tumor cell lines</subject><issn>1475-6366</issn><issn>1475-6374</issn><issn>1475-6374</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9UstuEzEUHSEQLYVPAI3EhgUT_LZng0ARj0qV2MDaumN7GlceO9iTovTr8ZA0oixY2b4-59zXaZqXGK0wUugdZpILKsSKIEJXBEuMiHrUnC_xTlDJHp_uQpw1z0q5QYhggtnT5owKiTmR5Ly5W0MeUoa4Dx1-q7oI2828geAnb13r4-yygQBzyqW-7M64NuxLKmmC0E5uGirVtVuXJweDD_4OZp9iC9G2o8s5bedU_EJtDUTjcmtcCG3w0ZXnzZMRQnEvjudF8-Pzp-_rr93Vty-X649XneGCzJ20mIgBqd6OYuBk4NbVPmjtEI1AR8alIUoxpbikMBDHZcViI0DY3va9ohfN5UHXJrjR2-wnyHudwOs_gZSvNeTZm-C0BcwcY6MSqmfUiH4EaQdJmCGCUDJUrfcHre1umJw1Ls4ZwgPRhz_Rb_R1utW9WmpEVeDNUSCnnztXZj35ssykjjHtiiayLrJHmC_Q1_9Ab9IuxzoqTXosORNKsIriB5TJqZTsxlMxGOnFKfreKXpxij46pfJe_d3JiXVvjQr4cAD4OKY8wa-Ug9Uz7EPKY9268UXT_-f4DYF7zr4</recordid><startdate>202312</startdate><enddate>202312</enddate><creator>Rykowski, Sebastian</creator><creator>Gurda-Woźna, Dorota</creator><creator>Fedoruk-Wyszomirska, Agnieszka</creator><creator>Orlicka-Płocka, Marta</creator><creator>Kowalczyk, Aleksandra</creator><creator>Stączek, Paweł</creator><creator>Denel-Bobrowska, Marta</creator><creator>Biniek-Antosiak, Katarzyna</creator><creator>Rypniewski, Wojciech</creator><creator>Wyszko, Eliza</creator><creator>Olejniczak, Agnieszka B.</creator><general>Taylor & Francis</general><general>Taylor & Francis Ltd</general><general>Taylor & Francis Group</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4416-8289</orcidid></search><sort><creationdate>202312</creationdate><title>Carboranyl-1,8-naphthalimide intercalators induce lysosomal membrane permeabilization and ferroptosis in cancer cell lines</title><author>Rykowski, Sebastian ; Gurda-Woźna, Dorota ; Fedoruk-Wyszomirska, Agnieszka ; Orlicka-Płocka, Marta ; Kowalczyk, Aleksandra ; Stączek, Paweł ; Denel-Bobrowska, Marta ; Biniek-Antosiak, Katarzyna ; Rypniewski, Wojciech ; Wyszko, Eliza ; Olejniczak, Agnieszka B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c562t-7d126b089df6b52b5de02133740fa3f457c288488573ab2e570891c6a6d9d9983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>1,8-naphthalimides</topic><topic>anticancer activity</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antitumor activity</topic><topic>Biology</topic><topic>Calf thymus</topic><topic>Cancer</topic><topic>Carborane</topic><topic>Cell cycle</topic><topic>Cell Line</topic><topic>Cell Line, Tumor</topic><topic>Chemistry</topic><topic>Circular dichroism</topic><topic>Cytotoxicity</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA - chemistry</topic><topic>DNA topoisomerase (ATP-hydrolysing)</topic><topic>Ferroptosis</topic><topic>Glutathione</topic><topic>Intercalating Agents</topic><topic>intercalation</topic><topic>Lipid peroxidation</topic><topic>Lysosomes - metabolism</topic><topic>Membrane potential</topic><topic>Naphthalimides</topic><topic>Neoplasms</topic><topic>Pharmaceutical sciences</topic><topic>Reactive oxygen species</topic><topic>Research Paper</topic><topic>Spectroscopy</topic><topic>Thermal denaturation</topic><topic>Thymus gland</topic><topic>Tumor cell lines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rykowski, Sebastian</creatorcontrib><creatorcontrib>Gurda-Woźna, Dorota</creatorcontrib><creatorcontrib>Fedoruk-Wyszomirska, Agnieszka</creatorcontrib><creatorcontrib>Orlicka-Płocka, Marta</creatorcontrib><creatorcontrib>Kowalczyk, Aleksandra</creatorcontrib><creatorcontrib>Stączek, Paweł</creatorcontrib><creatorcontrib>Denel-Bobrowska, Marta</creatorcontrib><creatorcontrib>Biniek-Antosiak, Katarzyna</creatorcontrib><creatorcontrib>Rypniewski, Wojciech</creatorcontrib><creatorcontrib>Wyszko, Eliza</creatorcontrib><creatorcontrib>Olejniczak, Agnieszka B.</creatorcontrib><collection>Taylor & Francis Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of enzyme inhibition and medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rykowski, Sebastian</au><au>Gurda-Woźna, Dorota</au><au>Fedoruk-Wyszomirska, Agnieszka</au><au>Orlicka-Płocka, Marta</au><au>Kowalczyk, Aleksandra</au><au>Stączek, Paweł</au><au>Denel-Bobrowska, Marta</au><au>Biniek-Antosiak, Katarzyna</au><au>Rypniewski, Wojciech</au><au>Wyszko, Eliza</au><au>Olejniczak, Agnieszka B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carboranyl-1,8-naphthalimide intercalators induce lysosomal membrane permeabilization and ferroptosis in cancer cell lines</atitle><jtitle>Journal of enzyme inhibition and medicinal chemistry</jtitle><addtitle>J Enzyme Inhib Med Chem</addtitle><date>2023-12</date><risdate>2023</risdate><volume>38</volume><issue>1</issue><spage>2171028</spage><pages>2171028-</pages><issn>1475-6366</issn><issn>1475-6374</issn><eissn>1475-6374</eissn><abstract>The synthesis of carborane-1,8-naphthalimide conjugates and evaluation of their DNA-binding ability and anticancer activity were performed. A series of 4-carboranyl-3-nitro-1,8-naphthalimide derivatives, mitonafide and pinafide analogs, were synthesised via amidation and reductive amination reactions, and their calf thymus DNA (ct-DNA)-binding properties were investigated using circular dichroism, UV-vis spectroscopy, and thermal denaturation. Results showed that conjugates 34-37 interacted very strongly with ct-DNA (ΔT
m
= 10.00-13.00 °C), indicating their ability to intercalate with DNA, but did not inhibit the activity of topoisomerase II. The conjugates inhibited the cell growth of the HepG2 cancer cell line in vitro. The same compounds caused the G2M phase arrest. Cell lines treated with these conjugates showed an increase in reactive oxygen species, glutathione, and Fe
2+
levels, lipid peroxidation, and mitochondrial membrane potential relative to controls, indicating the involvement of ferroptosis. Furthermore, these conjugates caused lysosomal membrane permeabilization in HepG2 cells but not in MRC-5 cells.</abstract><cop>England</cop><pub>Taylor & Francis</pub><pmid>36715272</pmid><doi>10.1080/14756366.2023.2171028</doi><orcidid>https://orcid.org/0000-0003-4416-8289</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1475-6366 |
ispartof | Journal of enzyme inhibition and medicinal chemistry, 2023-12, Vol.38 (1), p.2171028 |
issn | 1475-6366 1475-6374 1475-6374 |
language | eng |
recordid | cdi_pubmed_primary_36715272 |
source | Open Access: PubMed Central; Taylor & Francis Open Access; Publicly Available Content Database |
subjects | 1,8-naphthalimides anticancer activity Antineoplastic Agents - chemistry Antitumor activity Biology Calf thymus Cancer Carborane Cell cycle Cell Line Cell Line, Tumor Chemistry Circular dichroism Cytotoxicity Deoxyribonucleic acid DNA DNA - chemistry DNA topoisomerase (ATP-hydrolysing) Ferroptosis Glutathione Intercalating Agents intercalation Lipid peroxidation Lysosomes - metabolism Membrane potential Naphthalimides Neoplasms Pharmaceutical sciences Reactive oxygen species Research Paper Spectroscopy Thermal denaturation Thymus gland Tumor cell lines |
title | Carboranyl-1,8-naphthalimide intercalators induce lysosomal membrane permeabilization and ferroptosis in cancer cell lines |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T23%3A32%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carboranyl-1,8-naphthalimide%20intercalators%20induce%20lysosomal%20membrane%20permeabilization%20and%20ferroptosis%20in%20cancer%20cell%20lines&rft.jtitle=Journal%20of%20enzyme%20inhibition%20and%20medicinal%20chemistry&rft.au=Rykowski,%20Sebastian&rft.date=2023-12&rft.volume=38&rft.issue=1&rft.spage=2171028&rft.pages=2171028-&rft.issn=1475-6366&rft.eissn=1475-6374&rft_id=info:doi/10.1080/14756366.2023.2171028&rft_dat=%3Cproquest_pubme%3E2917546864%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c562t-7d126b089df6b52b5de02133740fa3f457c288488573ab2e570891c6a6d9d9983%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2917546864&rft_id=info:pmid/36715272&rfr_iscdi=true |